Masp2 Deficiency
Description
MASP2 deficiency, classically defined as MASP2 protein level of less than 100 ng/ml, occurs in about 4% of Caucasians and up to 18% of some African populations. Some MASP2-deficient individuals have increased risk of infection or autoimmune disease, but most are asymptomatic. MASP2 plays a role in activation of the lectin pathway of the complement system; deficiency may thus lead to defects in the complement system (summary by Thiel et al., 2007 and Sokolowska et al., 2015).For a discussion of genetic heterogeneity of lectin complement activation pathway defects, see LCAPD1 (OMIM ).
Genes related to Masp2 Deficiency
- MASP2
Clinical Features
Top most frequent phenotypes and symptoms related to Masp2 Deficiency
- Pica
- Pneumonia
- Erythema
- Myalgia
- Sepsis
- Recurrent pneumonia
- Vasculitis
- Systemic lupus erythematosus
- Colitis
- Ulcerative colitis
Incidence and onset information
— Not enough data available about incidence and published cases.
Accelerate your rare disease diagnosis with us
Masp2 Deficiency Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Complement deficiencies Panel.
By CeGaT GmbH in Germany.
PIGA, CFB, CFI, CFH, CD46, C3, THBD, C1S, C1R, CFHR1, CFHR3, DGKE, MASP1, C7, FCN3, CFD, C2, SERPING1, C1QC, C1QA , (...)
View the complete list with 14 more genes
Specificity
3 %
Genes
100 % |
MASP2.
By Fulgent Genetics Fulgent Genetics in United States.
MASP2
Specificity
100 %
Genes
100 % |
Complement System Disorder Panel.
By Blueprint Genetics in Finland.
CCDC39, PIGA, OFD1, CCNO, SPAG1, CCDC65, DNAAF4, RSPH1, ARMC4, ZMYND10, DRC1, CCDC114, LRRC6, DNAAF5, CCDC103, DNAAF3, DNAL1, CCDC40, DNAAF1, RSPH9 , (...)
View the complete list with 55 more genes
Specificity
2 %
Genes
100 % |
Alternate names
Masp2 Deficiency Is also known as lectin complement activation pathway, defect in, 2;lcapd2;.
If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM LUTHERAN NULL